Logotype for Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals (MDGL) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Madrigal Pharmaceuticals Inc

Proxy filing summary

28 Apr, 2026

Voting matters and shareholder proposals

  • Shareholders will vote on the re-election of three Class I directors: Julian Baker, Daniel Brennan, and James Daly.

  • An advisory vote will be held to approve executive compensation.

  • Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026 is on the agenda.

  • Approval of the 2026 Stock Plan and the 2026 Employee Stock Purchase Plan will be considered.

  • Other business matters may be addressed as appropriate during the meeting.

Board of directors and corporate governance

  • The board recommends voting in favor of all proposals presented at the annual meeting.

  • The meeting will be held virtually, allowing shareholders to participate online.

Executive compensation and say-on-pay

  • An advisory vote on executive compensation is included in the agenda, allowing shareholders to express their views.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more